Nudge BG 2025: Affordable Automated Insulin Delivery Algorithm Revolutionizing Diabetes Care
Discover how Nudge BG, a groundbreaking 2025 algorithm, is transforming automated insulin delivery by simplifying diabetes management and reducing user burden.

Leading diabetes innovator Lane Desborough is pioneering a new era in diabetes technology with Nudge BG, an intelligent algorithm designed to fully automate insulin delivery. This breakthrough aims to make diabetes management effortless and highly effective, requiring minimal input from users.
Just as “Intel Inside” revolutionized personal computing, Nudge BG aspires to become the trusted engine powering diabetes care across North America and beyond.
Based in California, Desborough combines his extensive engineering expertise and personal experience as a father of a child with type 1 diabetes to drive this innovative project forward. After a decade of leading roles at Medtronic and co-founding influential grassroots movements like #WeAreNotWaiting, he now channels his vision into Nudge BG.
Unlike current closed-loop systems that demand frequent user interaction such as logging carb intake and glucose levels, Nudge BG proposes a seamless, fully autonomous system that learns and adapts to each individual’s physiology and habits without constant manual adjustments.
Founded in early 2020, Nudge BG embodies the motto “Simpler is better,” focusing on accessibility for all people living with diabetes (PWD), not just those highly engaged in their therapy.
A Visionary Leader in Diabetes Innovation
Lane Desborough brings a unique blend of skills as an engineer, statistician, inventor, and athlete, holding more than a dozen patents. His work has shaped key diabetes technologies such as Medtronic’s Minimed pumps and continuous glucose monitoring systems, as well as inspiring the DIY diabetes community.
His career began in industrial automation before shifting to diabetes technology after his son’s diagnosis in 2009. This personal motivation fuels his relentless drive to improve lives.
The Origins of #WeAreNotWaiting
Desborough coined the phrase “we are not waiting” during the 2013 DiabetesMine D-Data Exchange, symbolizing the urgent push by the diabetes community to innovate outside traditional channels. This movement has led to groundbreaking projects like Nightscout and homemade automated insulin delivery systems, empowering thousands globally.
He also co-founded Bigfoot Biomedical, further cementing his role as a key influencer in diabetes tech before launching Nudge BG to take innovation even further.
What Is Nudge BG?
Rather than creating new hardware, Nudge BG is a sophisticated algorithm designed to integrate with existing insulin pumps and CGMs. It automatically adjusts insulin delivery based on continuous glucose data, eliminating the need for users to manually bolus for meals or corrections, though manual control remains available.
This smart system is designed to work quietly in the background, giving users peace of mind and the freedom to focus on life instead of constant diabetes management.
The algorithm learns from each user’s data over time to personalize insulin dosing, making it as easy to prescribe as a diabetes medication without requiring complex settings or user interfaces.
While a smartphone app is a potential delivery method, Desborough is also exploring licensing the technology directly to device manufacturers, ensuring broad accessibility.
Designed for Real Life, Not Just Power Users
Recognizing that most insulin-dependent individuals are not highly engaged with complex diabetes tech, Nudge BG is tailored for users seeking a low-maintenance solution. It avoids overwhelming notifications and unnecessary features, focusing on simplicity and emotional well-being.
Desborough likens it to providing a reliable car ride without the hassle of driving—he takes care of the technical details so users can simply enjoy the journey.
Inspired by the success of Abbott’s FreeStyle Libre, Nudge BG offers flexible engagement levels, allowing users to activate alerts or manage their care as much or as little as they prefer.
How Nudge BG Stands Apart
While other companies like Tidepool Loop, Diabeloop, TypeZero, ModeAGC, and CamAPS develop hybrid closed-loop algorithms that still require user input, Nudge BG aims to minimize user involvement, making automated insulin delivery accessible to a broader population.
By focusing on simplicity and adaptability, Nudge BG is positioned to lead the next wave of diabetes care innovation.
Although the launch timeline remains flexible to ensure quality and safety, Nudge BG’s agile software development model allows rapid response to emerging technologies and user needs.
As Desborough puts it, in the fast-changing diabetes tech landscape, Nudge BG is like "a mammal thriving in a dinosaur world," ready to evolve and support people living with diabetes in 2024 and beyond.
Discover engaging topics and analytical content in Sexual Wellness as of 12-04-2021. The article titled " Nudge BG 2025: Affordable Automated Insulin Delivery Algorithm Revolutionizing Diabetes Care " provides new insights and practical guidance in the Sexual Wellness field. Each topic is meticulously analyzed to deliver actionable information to readers.
The topic " Nudge BG 2025: Affordable Automated Insulin Delivery Algorithm Revolutionizing Diabetes Care " helps you make smarter decisions within the Sexual Wellness category. All topics on our website are unique and offer valuable content for our audience.


